University of California Los Angeles (UCLA) (Adults and Pediatrics) is a clinical research site located in Los Angeles, California, United States 90095.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
University of California Los Angeles (UCLA) (Adults and Pediatrics) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD).
Sponsors: Pierre Fabre Medicament.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of California Los Angeles (UCLA) (Adults and Pediatrics) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of California Los Angeles (UCLA) (Adults and Pediatrics) has 1 clinical trials on record, with 1 currently active. Their work covers Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD).
University of California Los Angeles (UCLA) (Adults and Pediatrics) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.